|
|
DAP-Santé Consulting
Bringing Life Sciences Research to Healthcare
Markets Drug Discovery Research Consulting |
|
Examples of DAP-Santé services:
Development of First-in-Class
small molecules for cancer therapy with an original anti-vascular and
anti-proliferative mechanism of action with Ecrins Therapeutics (Grenoble,
France).
Development of IDO1
(indoleamine-2, 3-dioxygenase-1) and TDO (tryptophan-2, 3-dioxygenase)
inhibitors to develop cancer immunotherapeutics with Curadev (New Delhi),
currently exclusive license agreement with Roche.
Clinical and Pharmaceutical
Development of theranostic nanoparticles for solid cancers with NH TherAguix
(Lyon, Grenoble, France).
Initiation of clinical trial with
theranostic nanoparticles on pancreatic cancer with NH TherAguix and Harvard
Medical School (Boston).
Initiation of clinical trial with
theranostic nanoparticles on cerebral metastases with NH TherAguix and Centre
Léon Bérard (Lyon, France). |
Confidentiality is guaranteed and agreed deadlines are fully
respected.